Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4861
-
4862
Identification of +TIPs required for MT plus-end targeting of dynein-dynactin in the <i>C</i>. <i>elegans</i> early embryo.
Published 2017“…<b>(C)</b> Cortical confocal section in one-cell embryos co-expressing GFP::p50<sup>DNC-2</sup> and EBP-2::mKate2, showing that depletion of dynein intermediate chain<sup>DYCI-1</sup> or LIS-1 decreases dynactin levels at MT plus ends. …”
-
4863
-
4864
-
4865
-
4866
The percentage of cells with protein aggregates cotransfected with αA- and αB-crystallin or R120G αB-crystallin (αBM) genes
Published 2011“…</p><p></p> The x-axis labels are either RED-αB- or the pairs of GFP-αA- and RED-αB-crystallin. A four-fold decrease of cells with protein aggregates was observed for cotransfection of αA- and αB-crystallin (the asterisk indicates a p=0.006), but only about a 1.5 fold decrease for cotransfection of αA- and αBM-crystallin (the double asterisk indicates a p=0.02). …”
-
4867
Disorder–Order Structural Transformation in Electron-Poor Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> Driven by Chemical Bonding Optimization
Published 2013“…Single-crystal X-ray diffraction analyses revealed that Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> has a La<sub>3</sub>Al<sub>11</sub>-type <i>Immm</i> structure (<i>a</i> = 4.6767(8) Å, <i>b</i> = 9.646(2) Å, <i>c</i> = 14.170(2) Å, <i>Z</i> = 2) if annealed at 550 °C and above but a Ca<sub>3</sub>Au<sub>8</sub>Ge<sub>3</sub>-type structure (<i>Pnnm</i>, <i>a</i> = 9.6082(8) Å, <i>b</i> = 14.171(1) Å, <i>c</i> = 4.6719(4) Å, <i>Z</i> = 2) if annealed at 400 °C. …”
-
4868
Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity.
Published 2017“…<p><b>(A)</b> Cartoon of the dynactin complex and its interaction with MTs and end-binding protein (EB). …”
-
4869
-
4870
-
4871
-
4872
Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma
Published 2015“…On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. …”
-
4873
Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach
Published 2017“…Maturity-onset diabetes of the young type 3 (MODY3) is a non-ketotic form of diabetes associated with poor insulin secretion. …”
Get full text
Get full text
-
4874
The C-terminal tyrosine of α-tubulin is required for centration/rotation of the nucleus-centrosome complex but not for MT tip tracking of dynactin.
Published 2017“…<b>(I)</b> <i>(left)</i> Cortical confocal section of a control and <i>tba-1/2(YA/YA)</i> one-cell embryo in metaphase expressing GFP::p50<sup>DNC-2</sup>. …”
-
4875
Morphological schematic diagram of <i>A</i>. <i>Adenophora</i>.
Published 2024“…The phytochemical variability of the extracts was also studied. The LC<sub>50</sub> value of the <i>A</i>. <i>adenophora</i> extract against <i>L</i>. …”
-
4876
-
4877
-
4878
Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection
Published 2022“…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
-
4879
Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection
Published 2022“…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
-
4880